Senate Bill No. 1011
Public Act No. 21-108
AN ACT CONCERNING THE USE OF OPIOID ANTAGONISTS BY
POLICE OFFICERS AND STUDYING THE USE OF EPINEPHRINE
CARTRIDGE INJECTORS BY POLICE OFFICERS.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective from passage) (a) As used in this section, (1)
"law enforcement unit" and "police officer" have the same meanings as
provided in section 7-294a of the general statutes, and (2) "opioid
antagonist" has the same meaning as provided in section 17a-714a of the
general statutes.
(b) Each law enforcement unit shall (1) require its police officers to
receive training in the use of an opioid antagonist, and (2) acquire and
maintain a supply of opioid antagonists for use by its police officers
when responding to a medical emergency. Any police officer who
completes such training shall be permitted to carry and administer an
opioid antagonist to an individual whom the officer believes in good
faith is experiencing an opioid-related drug overdose.
Sec. 2. (Effective from passage) (a) As used in this section, (1)
"epinephrine cartridge injector" has the same meaning as provided in
section 19a-909 of the general statutes, and (2) "law enforcement unit"
and "police officer" have the same meanings as provided in section 7- Senate Bill No. 1011
Public Act No. 21-108 2 of 3
294a of the general statutes.
(b) The Police Officer Standards and Training Council, in
consultation with the Departments of Emergency Services and Public
Protection and Public Health, shall convene a working group to examine
and make recommendations regarding the feasibility of requiring police
officers to carry and administer an epinephrine cartridge injector to an
individual whom the officer believes in good faith is experiencing
anaphylaxis. At a minimum, the working group shall (1) determine if
the need for such requirement exists by examining data on the use of
epinephrine cartridge injectors by police officers and other first
responders and balancing the potential benefit to the public with the
potential impact to the police officer and law enforcement unit, (2)
address issues associated with such requirement, including the cost of
implementation and training police officers in the administration of
epinephrine cartridge injectors, (3) consult a medical expert regarding
the shelf life and safe storage practices of epinephrine cartridge
injectors, and (4) if the working group determines the need for such
requirement exists, make recommendations for legislation regarding
implementation.
(c) Not later than January 1, 2023, the council shall submit a report on
the findings and recommendations of the working group to the joint
standing committee of the General Assembly having cognizance of
matters relating to public safety and security, in accordance with the
provisions of section 11-4a of the general statutes. The working group
shall terminate on the date that the commissioner and council submit
such final report or January 1, 2023, whichever is later.
Senate Bill No. 1011
Public Act No. 21-108 3 of 3
Certified as correct by
_____________________________________________________________________
Legislative Commissioner.
_____________________________________________________________________
Clerk of the Senate.
_____________________________________________________________________
Clerk of the House.
Approved ________________________________________________, 2021
_____________________________________________________________________
Governor, State of Connecticut.